United States · FDA National Drug Code directory
Enoxaparin Sodium
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 63323-539_a12d41f8-475d-4932-9aa0-73180eb1fd60
- Product NDC
- 63323-539
- Form
- INJECTION
- Composition / generic term
- enoxaparin sodium
- Labeler
- Fresenius Kabi USA, LLC
- Marketing category
- NDA AUTHORIZED GENERIC
- Marketing start / end (source format)
- 20190618
- Source listing expiry
- 20271231
Source-listed ingredients
- ENOXAPARIN SODIUM — 300 mg/3mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 VIAL, MULTI-DOSE in 1 CARTON (63323-539-13) / 3 mL in 1 VIAL, MULTI-DOSE · 63323-539-13
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →